Voltage-gated T-type calcium channel
Family in Homo sapiens that 8 drugs act on.
- Drugs that act on it: 8
- Approved: 6
- In phases 1 to 3: 2
- Sponsors: 5
- Genes: 3
Who is on it, and how far along
Every drug ChEMBL records acting on CACNA1G, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 8
Approved6
Phase 30
Phase 22
Phase 10
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Pfizer338%
- AbbVie225%
- Cavion113%
- Idorsia Pharmaceuticals Ltd.113%
- Jazz Pharmaceuticals113%
| Ethosuximide | Approved | Pfizer | Small molecule | Blocker | 2 |
| MibefradilWithdrawn | Approved | Cavion | Small molecule | Blocker | 1 |
| Methsuximide | Approved | Pfizer | Small molecule | Blocker | 0 |
| Paramethadione | Approved | AbbVie | Small molecule | Blocker | 0 |
| Phensuximide | Approved | Pfizer | Small molecule | Blocker | 0 |
| Trimethadione | Approved | AbbVie | Small molecule | Blocker | 0 |
| Apinocaltamide | Phase 2 | Idorsia Pharmaceuticals Ltd. | Small molecule | Blocker | 0 |
| Suvecaltamide | Phase 2 | Jazz Pharmaceuticals | Small molecule | ModulatorVoltage-gated T-type calcium channel modulator | 0 |
| Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study | Mibefradil | — | Not yet recruiting | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | Dec 4, 2025 |
| Ketogenic Diet for New-Onset Absence Epilepsy | Ethosuximide | Phase 3 | Recruiting | Johns Hopkins University | Feb 18, 2020 |
| Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome | Ethosuximide | Phase 3 | Recruiting | Tanta University | Jan 3, 2020 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2362995, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets